NCT07258121 2025-12-02
Study of ZGGS34 in Participants With Advanced Solid Tumors
Suzhou Zelgen Biopharmaceuticals Co.,Ltd
Phase 1/2 Not yet recruiting
Clinical Trials
8 trialsNCT05982522 2025-04-30
IN10018 Combination Therapy in Previously-treated Solid Tumors
InxMed (Shanghai) Co., Ltd.
Phase 1/2 Not yet recruiting
NCT06949761 2025-04-29
A Clinical Study to Evaluate the Safety, Tolerability, and Efficacy of QLC1101 in Combination With Other Therapies in the Treatment of Patients With Advanced Solid Tumors Harboring a KRAS G12D Mutation
Qilu Pharmaceutical Co., Ltd.
Phase 1/2 Not yet recruiting
NCT05954091 2024-12-27
OH2 Administered by Intratumoral Injection
Binhui Biopharmaceutical Co., Ltd.
Phase 1 Not yet recruiting
NCT06613152 2024-09-25
HS-IT201 Injection in the Treatment of Advanced Solid Tumors
Qingdao Sino-Cell Biomedicine Co., Ltd.
Phase EARLY_PHASE1 Not yet recruiting
NCT06245018 2024-02-07
A Trial to Evaluate the Safety and Preliminary Efficacy of iNK in the Treatment of Subjects With Solid Tumor
Nuwacell Biotechnologies Co., Ltd.
Phase NA Not yet recruiting
NCT05971576 2023-08-02
A Clinical Study on TILs for the Treatment of Advanced Solid Tumors
Suzhou BlueHorse Therapeutics Co., Ltd.
Phase EARLY_PHASE1 Not yet recruiting
NCT05971589 2023-08-02
A Clinical Study on LM103 Injection for the Treatment of Advanced Solid Tumors
Suzhou BlueHorse Therapeutics Co., Ltd.
Phase EARLY_PHASE1 Not yet recruiting